Potential for personalised immunotherapy extended to large variety of cancers
A new study shows that ovarian cancer, which has proved resistant to currently available immunotherapies,…
A new study shows that ovarian cancer, which has proved resistant to currently available immunotherapies,…
A discovery by Melbourne researchers could help to identify patients with a particularly aggressive type…
Johns Hopkins researchers have invented a new class of cancer immunotherapy drugs that are more…
A clinical trial of a new immunotherapy that will deliver a “toxin bomb” to brain…
The Therapeutic Goods Administration has approved pembrolizumab (KEYTRUDA 200mg, every three weeks) as monotherapy for…
Johns Hopkins scientists have used a form of artificial intelligence to create a map that…
Immunotherapy, which helps the body’s immune system attack cancer, has revolutionised treatment for cancers such…
In the Jan. 5, 2018 issue of Science, researchers from the University of Chicago Medicine show…
A common, inexpensive drug that is used to prevent heart attacks and lower blood pressure…
A team of scientists at the Keck School of Medicine of USC is looking to…